Precision Antibody to Showcase Cutting-Edge Monoclonal Antibody Services at the PEGS Europe Summit
The leading provider of custom monoclonal antibody services is set to highlight its expertise in antibody discovery and engineering at the 16th Annual PEGS Europe Summit in Barcelona.
- (1888PressRelease) November 08, 2024 - Baltimore, MD - Precision Antibody, a leading provider of custom monoclonal antibody development services, is thrilled to announce its role as a Corporate Support Sponsor of the prestigious 16th Annual PEGS Europe Protein & Antibody Engineering Summit, taking place from November 5-7, 2024, at the Montjuïc Palau de Congressos in Barcelona, Spain. Widely regarded as Europe’s premier biologics technology event, PEGS Europe convenes top scientists and innovators to drive advancements in protein and antibody engineering, providing an unparalleled platform for collaboration and discovery.
As a trusted partner in the pharmaceutical and biotechnology sectors, Precision Antibody specializes in developing high-quality, custom monoclonal and polyclonal antibodies for both research and therapeutic and diagnostic applications. With over 25 years of expertise, the company has been pivotal in advancing critical research in oncology, autoimmune diseases, infectious diseases, neurology, and more. Precision Antibody’s sponsorship of PEGS Europe 2024 underscores its commitment to pushing the boundaries of antibody-based therapies and innovation.
“PEGS Europe is a cornerstone for professionals in the biologics community, and we’re excited to be part of this dynamic event,” said Dr. Jun Hayashi, President of Precision Antibody. “Our mission is to empower researchers and biopharma companies in their journey to develop life-changing therapies. PEGS Europe offers the ideal setting to showcase our services, connect with like-minded innovators, and explore new partnerships.”
An Agenda Packed with Cutting-Edge Science
The 2024 PEGS Europe Summit promises a comprehensive program covering the latest breakthroughs in biologics. Key topics for this year include:
• Antibody-Based Therapies
• Bispecific and Multispecific Antibodies
• Next-Generation Immunotherapies
• Protein Stability & Formulation
• Machine Learning for Antibody Engineering
Attendees will gain invaluable insights from world-renowned scientists and industry leaders, while Precision Antibody is eager to participate in discussions on bispecific antibodies and antibody-drug conjugates (ADCs), areas central to its ongoing research and development.
Collaborating with Industry Leaders
The summit will feature presentations from esteemed experts, including:
• Christian Klein, PhD, Head of Oncology Programs at Roche Innovation Center Zurich, discussing the future of bispecific antibodies in cancer therapy.
• Bruce Keyt, PhD, Chief Scientific Officer at IGM Biosciences, highlighting pioneering antibody therapeutics for colorectal carcinoma.
• Patrick Barth, PhD, Associate Professor at EPFL, speaking on computational design of membrane protein therapeutics.
Precision Antibody is excited to engage in these conversations and contribute its knowledge in antibody discovery and development. By sponsoring this event, the company reaffirms its leadership role in advancing therapeutic antibody innovation.
Showcasing Expertise in Antibody Engineering
Throughout the event, Precision Antibody will feature its comprehensive antibody services, from early-stage discovery and screening to final product development. These services include high-affinity monoclonal antibody generation, bispecific antibody development, and custom protein expression, all designed to expedite breakthroughs in therapeutic research.
“We are dedicated to providing customized solutions that accelerate the development of antibody-based therapies,” added Dr. Hayashi. “Each project we undertake is unique, and we collaborate closely with our clients to ensure they receive the highest quality antibodies, perfectly suited to their specific research needs.”
As a Corporate Support Sponsor, Precision Antibody warmly invites all attendees to connect with its team during the event. Representatives will be available to discuss how their tailored antibody solutions can support a wide range of research and development initiatives, from early discovery through to commercialization. Whether it’s custom antibody generation, antigen design, or advanced screening services, Precision Antibody offers comprehensive solutions backed by decades of expertise.
Precision Antibody will also demonstrate its ability to help clients overcome challenges in antibody engineering, from improving target specificity to addressing protein expression issues. Through state-of-the-art technologies and a collaborative approach, Precision Antibody is committed to helping researchers achieve their scientific and therapeutic goals.
Why Attend PEGS Europe 2024?
PEGS Europe 2024 is a must-attend event for professionals involved in biologics research and development. With over 1,500 attendees, the summit offers a rare opportunity to gain insights from leading experts, discover cutting-edge innovations, and form valuable connections across the biopharmaceutical landscape. Precision Antibody’s sponsorship highlights its dedication to fostering collaboration, driving innovation, and advancing the future of antibody-based therapies.
Attendees are encouraged to visit Precision Antibody’s booth to learn how the company’s custom monoclonal antibody development services can propel their research and therapeutic projects forward. To schedule a meeting with Precision Antibody at PEGS Europe 2024, please contact us at info ( @ ) precisionantibody dot com
Let’s collaborate to drive the future of antibody therapeutics!
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam